Is J&J's (JNJ) Pharma Segment Likely to Drive Q1 Earnings?

Johnson & Johnson JNJhas one of the most diverse revenue streams in the industry within the pharmaceutical division that accounts for almost half of its revenues. The company has several multi-million dollar drugs covering a broad range of areas such as neuroscience, cardiovascular and metabolism; immunology; oncology; pulmonary hypertension; and infectious diseases/vaccines.

However, several products in this segment are facing generic competition.